Fig. 2.

a: Change of PANSS score in patients with schizophrenic who were treated with aripiprazole oral solution for 12 weeks. b: Comparison of the decrease of PANSS scores between agitated and no-agitated schizophrenia patients treated with aripiprazole oral solution for 12 weeks. c: Comparison of the decrease of PANSS scores between first-episode and chronic schizophrenia patients treated with aripiprazole oral solution for 12 weeks. d: Change of abnormal percentage of prolactin and waistline in patients with schizophrenic who were treated with aripiprazole oral solution for 12 weeks. *There is a significant difference in the PANSS score reduction from baseline (Fig. 2a). *There is a significant difference in the PANSS score reduction between the two groups (Fig. 2bcd). *P < 0.05, **P < 0.01, ***P < 0.001